| Code | 0661C | ||||||||||
| MA number | 27/0311/06-S | ||||||||||
| Product Form: | tbl plg 84x2 mg (blis.PVC/PE/PVdC-Al/papier-bezpeč.blis.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 09.08.2006 |
| SPC: |
SPC_REQUIP-MODUTAB_06.2023.pdf
|
| PIL: |
PIL_REQUIP-MODUTAB_06.2023.pdf
|
| Safety feature | Yes |
| Data update: | 10.04.2018 |
